Relapsed or Refractory Chronic Lymphocytic Leukemia
specificA chronic lymphocytic leukemia that is resistant to treatment.
5
Centers
1
Active Trials
—
Cancer Funding
Top Centers for Relapsed or Refractory Chronic Lymphocytic Leukemia(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Princess Margaret Cancer CentreToronto, ON High-Volume Research Center | 78.0 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 55.5 |
| 3 | Cleveland Clinic Cancer CenterCleveland, OH | 55.5 |
| 4 | University of Illinois Cancer CenterChicago, IL | 55.5 |
| 5 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 55.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →